Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

• Main Authors: Yao Rodion Konu (Author), Fifonsi Adjidossi Gbeasor-Komlanvi (Author), Mouhoudine Yerima (Author), Arnold Junior Sadio (Author), Martin Kouame Tchankoni (Author), Wendpouire Ida Carine Zida-Compaore (Author), Josée Nayo-Apetsianyi (Author), Kossivi Agbélénko Afanvi (Author), Sibabe Agoro (Author), Mounerou Salou (Author), Dadja Essoya Landoh (Author), Atany B. Nyansa (Author), Essohanam Boko (Author), Moustafa Mijiyawa (Author), Didier Koumavi Ekouevi (Author)
• Format: Book
• Published: BMC, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The coronavirus disease 2019 (COVID-19) vaccines can cause adverse events that can lead to vaccine hesitancy. This study aims at estimating the prevalence of severe adverse events (SAEs) and their associated factors among health professionals vaccinated with ChAdOx1 nCoV-19 vacci...